While the Free State health department is denying that clinics in the province are experiencing stockouts of antiretroviral medicines, some healthcare users and HIV activists working in communities claim otherwise. The department does however acknowledge that some people are given only a two-week supply at a time. Refilwe Mochoari reports.
In Spotlight’s analysis of South Africa’s HIV response in recent years, two issues have stood out consistently – still too many people living with HIV are not taking antiretroviral therapy and the rate of new HIV infections in South Africa is not coming down fast enough. Accordingly, argues Spotlight editor Marcus Low, we must accelerate the shift toward an HIV response where we make testing for HIV and taking antiretroviral treatment as convenient as possible.
Telling a child that he or she is living with HIV is not easy. Biénne Huisman spoke to a father and some doctors on how one approaches the issue.
On December 12, Ntimbwe Munongo Mpamba will celebrate his fortieth birthday with chocolate cake in Northgate, Johannesburg. He was born with HIV but only became aware of his HIV status many years later. Biénne Huisman spoke to him about living with HIV, his early years when his mother fed him medicine disguised as sweets, and now, living openly as an HIV awareness champion.
KwaZulu-Natal clinics are outperforming facilities monitored in other provinces on various indicators and health services in the province have improved year-on-year, but some marginalised groups continue to have a hard time accessing healthcare services. This is according to the latest provincial report from community-led monitoring project Ritshidze. Nthusang Lefafa spoke to several NGOs about the findings and asked the province’s health department for their response.
South Africa is expected to begin piloting the HIV prevention injection early next year as one of several projects that experts hope will reveal the answers to some of the biggest questions about the future of the shot – who will deliver the injection, where, and how to sell people on the idea that just six shots a year could protect them from HIV. Laura Lopez Gonzalez reports.
South Africa is expected to begin piloting the every-other-month HIV prevention shot early next year, according to the international medicine financing initiative Unitaid. New modelling shows that the injection could prevent as many as 52 000 new HIV infections in the next two decades. But to be cost-effective in South Africa, the research argues, the price of the injection must fall to levels drugmaker ViiV Healthcare says are unrealistic. Laura Lopez Gonzalez reports.
A recently published report by the community-led clinic monitoring project, Ritshidze shows that while there have been pockets of improvements at some clinics in the Free State, there are key issues on which facilities’ performance has worsened, especially for people living with HIV. Refilwe Mochoari unpacks the report’s findings zooming in on the situation at Bloemspruit Clinic in Mangaung.
The Treatment Action Campaign (TAC) elected new leadership at its recently held seventh national congress. Thabo Molelekwa attended the congress and asked TAC leaders about the organisation’s focus in 2022 and beyond.
Elri Voigt summarises some of the latest developments on long-acting therapies for HIV presented at the 2022 International AIDS conference.
It is estimated that in 2021, around 0.3% of sexually active people in the Western Cape were taking antiretroviral medicines to prevent HIV infection. This is substantially lower than the national estimate of 1%. Elsabé Brits asks why uptake in the Western Cape is lagging behind most other provinces.
The world stands at an inflection point once more in the war against HIV. For those of us working in the field in South Africa, especially, it feels eerily like the battle that was fought 25 years ago, writes Dr Liesl Page-Shipp.
